NTRA
Natera, Inc.
Is NTRA Halal?
Genetic diagnostics — prenatal and cancer testing is permissible medical science.
What You Should Know
Natera develops cell-free DNA testing technology used for prenatal screening (Panorama), cancer monitoring (Signatera), and organ transplant rejection detection (Prospera). These are diagnostic tools that help patients and physicians make informed medical decisions. Medical diagnostics is entirely permissible — detecting disease and protecting health (hifz al-nafs) is highly valued in Islamic ethics. Not yet profitable; still investing in commercial scale. Some scholars debate certain genetic testing applications, but diagnostic (not eugenic) uses are generally accepted.
⚠️ Concerns
- •Not yet profitable — high R&D spending
- •Prenatal testing used for non-medical decisions by some (application concern, not the product)
- •Minor interest income on cash
- •High valuation relative to revenue
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →